By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Insider activity at Idexx Laboratories Inc has been all selling for a year now: about $37.7 million from six sellers, and zero buyers on the open market.
That's worth context: executives sell for plenty of routine reasons, from scheduled trading plans to tax bills. Buying is the rarer, more telling signal.
IDXX also shows up in congressional disclosures: 17 reported trades from four lawmakers in two years. Last full quarter: net selling by insiders. Insiders bought in 0 of the last 7 full quarters. Big money check: 1,300 institutions held IDXX as of Q2 2026, and funds were split between buying and selling.
Are insiders buying or selling IDXX stock?
In the last 12 months Idexx Laboratories Inc insiders made open-market purchases worth about $0 and sales worth about $37.7 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in IDXX?
The most recent open-market insider trade in IDXX was filed on 2026-09-09.
How many institutions own IDXX?
1,300 investment managers reported holding IDXX in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded IDXX?
Yes. Members of Congress reported 17 trades in IDXX over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).